脓毒症患者主要不良心血管事件研究进展
Research Progress on Major Adverse Cardiovascular Events in Sepsis Patients
摘要: 脓毒症是由于宿主对感染的反应失调引起的可能危及生命的器官功能障碍的疾病,而循环系统是脓毒症主要累及的系统之一。近年来,已有大量文献证实了脓毒症患者发生主要不良心血管事件的风险升高,本文通过回顾相关文献,重点从脓毒症与心血管疾病的病理生理机制之间的联系、导致脓毒症患者主要不良心血管事件发生的相关危险因素、可能预测其发生的生物标志物以及针对脓毒症患者主要不良心血管事件发生的预测模型的建立与应用几方面进行综述,旨在为脓毒症患者主要不良心血管事件的发生提供新的研究思路。
Abstract: Sepsis is a potentially life-threatening organ dysfunction disease caused by the imbalance in the host’s response to infection, and the circulatory system is one of the main systems affected by sepsis. In recent years, a large amount of literature has confirmed that sepsis patients have an increased risk of major adverse cardiovascular events. This article reviews relevant literature, focusing on the relationship between sepsis and the pathophysiological mechanisms of cardiovascular disease, the related risk factors that lead to major adverse cardiovascular events in sepsis patients, potential biomarkers that may predict their occurrence, and the establishment and application of prediction models for major cardiovascular adverse events in sepsis patients. The aim is to provide new research ideas for the occurrence of major adverse cardiovascular events in sepsis patients.
文章引用:贾心雨, 林可. 脓毒症患者主要不良心血管事件研究进展[J]. 临床医学进展, 2025, 15(10): 1194-1202. https://doi.org/10.12677/acm.2025.15102872

参考文献

[1] Singer, M., Deutschman, C.S., Seymour, C.W., Shankar-Hari, M., Annane, D., Bauer, M., et al. (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315, 801-810. [Google Scholar] [CrossRef] [PubMed]
[2] Gentile, L.F., Cuenca, A.G., Efron, P.A., Ang, D., Bihorac, A., McKinley, B.A., et al. (2012) Persistent Inflammation and Immunosuppression: A Common Syndrome and New Horizon for Surgical Intensive Care. Journal of Trauma and Acute Care Surgery, 72, 1491-1501. [Google Scholar] [CrossRef] [PubMed]
[3] Kosyakovsky, L.B., Angriman, F., Katz, E., Adhikari, N.K., Godoy, L.C., Marshall, J.C., et al. (2021) Association between Sepsis Survivorship and Long-Term Cardiovascular Outcomes in Adults: A Systematic Review and Meta-Analysis. Intensive Care Medicine, 47, 931-942. [Google Scholar] [CrossRef] [PubMed]
[4] Falk, G.E., Rogers, J., Lu, L., Ablah, E., Okut, H. and Vindhyal, M.R. (2022) Sepsis, Septic Shock, and Differences in Cardiovascular Event Occurrence. Journal of Intensive Care Medicine, 37, 1528-1534. [Google Scholar] [CrossRef] [PubMed]
[5] 李琦, 沈丽娟, 陈家豪, 等. NLRP3炎症小体在脓毒症心肌损伤中的作用[J]. 国际心血管病杂志, 2025, 52(1): 21-24.
[6] Soriano, F.G., Nogueira, A.C., Caldini, E.G., Lins, M.H., Teixeira, A.C., Cappi, S.B., et al. (2006) Potential Role of Poly(Adenosine 5’-Diphosphate-Ribose) Polymerase Activation in the Pathogenesis of Myocardial Contractile Dysfunction Associated with Human Septic Shock. Critical Care Medicine, 34, 1073-1079. [Google Scholar] [CrossRef] [PubMed]
[7] Rudiger, A. and Singer, M. (2007) Mechanisms of Sepsis-Induced Cardiac Dysfunction. Critical Care Medicine, 35, 1599-1608. [Google Scholar] [CrossRef] [PubMed]
[8] Aird, W.C. (2003) The Role of the Endothelium in Severe Sepsis and Multiple Organ Dysfunction Syndrome. Blood, 101, 3765-3777. [Google Scholar] [CrossRef] [PubMed]
[9] Angriman, F., Rosella, L.C., Lawler, P.R., Ko, D.T., Wunsch, H. and Scales, D.C. (2022) Sepsis Hospitalization and Risk of Subsequent Cardiovascular Events in Adults: A Population-Based Matched Cohort Study. Intensive Care Medicine, 48, 448-457. [Google Scholar] [CrossRef] [PubMed]
[10] Wu, M., Tsou, P., Wang, Y., Lee, M.G., Chao, C.C.T., Lee, W., et al. (2019) Impact of Post-Sepsis Cardiovascular Complications on Mortality in Sepsis Survivors: A Population-Based Study. Critical Care, 23, Article No. 293. [Google Scholar] [CrossRef] [PubMed]
[11] 汤云霞, 黄翯. 女性心血管疾病现状及性别特异性危险因素分析[J]. 心电与循环, 2024, 43(6): 544-549.
[12] Gotts, J.E. and Matthay, M.A. (2016) Sepsis: Pathophysiology and Clinical Management. BMJ, 353, i1585. [Google Scholar] [CrossRef] [PubMed]
[13] Jentzer, J.C., Lawler, P.R., Van Houten, H.K., Yao, X., Kashani, K.B. and Dunlay, S.M. (2023) Cardiovascular Events among Survivors of Sepsis Hospitalization: A Retrospective Cohort Analysis. Journal of the American Heart Association, 12, e027813. [Google Scholar] [CrossRef] [PubMed]
[14] Angriman, F., Lawler, P.R., Shah, B.R., Martin, C.M. and Scales, D.C. (2023) Prevalent Diabetes and Long-Term Cardiovascular Outcomes in Adult Sepsis Survivors: A Population-Based Cohort Study. Critical Care, 27, Article No. 302. [Google Scholar] [CrossRef] [PubMed]
[15] Angriman, F., Rosella, L.C., Lawler, P.R., Ko, D.T., Martin, C.M., Wunsch, H., et al. (2023) Risk Factors for Major Cardiovascular Events in Adult Sepsis Survivors: A Population-Based Cohort Study. Critical Care Medicine, 51, 471-483. [Google Scholar] [CrossRef] [PubMed]
[16] Angriman, F., Rosella, L.C., Lawler, P.R., Ko, D.T., Martin, C.M., Wunsch, H., et al. (2023) Renin-Angiotensin System Inhibitors and Major Cardiovascular Events after Sepsis. Annals of the American Thoracic Society, 20, 414-423. [Google Scholar] [CrossRef] [PubMed]
[17] Hsieh, Y., Tsou, P., Wang, Y., Chao, C.C., Lee, W., Lee, M.G., et al. (2019) Risk Factors for Myocardial Infarction and Stroke among Sepsis Survivors: A Competing Risks Analysis. Journal of Intensive Care Medicine, 35, 34-41. [Google Scholar] [CrossRef] [PubMed]
[18] Custodero, C., Wu, Q., Ghita, G.L., Anton, S.D., Brakenridge, S.C., Brumback, B.A., et al. (2019) Prognostic Value of NT-proBNP Levels in the Acute Phase of Sepsis on Lower Long-Term Physical Function and Muscle Strength in Sepsis Survivors. Critical Care, 23, Article No. 230. [Google Scholar] [CrossRef] [PubMed]
[19] Brueckmann, M., Huhle, G., Lang, S., Haase, K.K., Bertsch, T., Weiß, C., et al. (2005) Prognostic Value of Plasma N-Terminal Pro-Brain Natriuretic Peptide in Patients with Severe Sepsis. Circulation, 112, 527-534. [Google Scholar] [CrossRef] [PubMed]
[20] Post, F., Weilemann, L.S., Messow, C., Sinning, C. and Münzel, T. (2008) B-Type Natriuretic Peptide as a Marker for Sepsis-Induced Myocardial Depression in Intensive Care Patients. Critical Care Medicine, 36, 3030-3037. [Google Scholar] [CrossRef] [PubMed]
[21] Lörstad, S., Shekarestan, S., Jernberg, T., Tehrani, S., Åstrand, P., Gille-Johnson, P., et al. (2023) First Sampled High-Sensitive Cardiac Troponin T Is Associated with One-Year Mortality in Sepsis Patients and 30-to 365-Day Mortality in Sepsis Survivors. The American Journal of Medicine, 136, 814-823.e8. [Google Scholar] [CrossRef] [PubMed]
[22] Garcia, M.A., Rucci, J.M., Thai, K.K., Lu, Y., Kipnis, P., Go, A.S., et al. (2021) Association between Troponin I Levels during Sepsis and Postsepsis Cardiovascular Complications. American Journal of Respiratory and Critical Care Medicine, 204, 557-565. [Google Scholar] [CrossRef] [PubMed]
[23] Póvoa, P., Coelho, L., Dal-Pizzol, F., Ferrer, R., Huttner, A., Conway Morris, A., et al. (2023) How to Use Biomarkers of Infection or Sepsis at the Bedside: Guide to Clinicians. Intensive Care Medicine, 49, 142-153. [Google Scholar] [CrossRef] [PubMed]
[24] Lobo, S.M.A., Lobo, F.R.M., Bota, D.P., Lopes-Ferreira, F., Soliman, H.M., Meélot, C., et al. (2003) C-Reactive Protein Levels Correlate with Mortality and Organ Failure in Critically Ill Patientsa. Chest, 123, 2043-2049. [Google Scholar] [CrossRef] [PubMed]
[25] Koozi, H., Lengquist, M. and Frigyesi, A. (2020) C-Reactive Protein as a Prognostic Factor in Intensive Care Admissions for Sepsis: A Swedish Multicenter Study. Journal of Critical Care, 56, 73-79. [Google Scholar] [CrossRef] [PubMed]
[26] Yu, Y., Wu, W., Dong, Y. and Li, J. (2021) C‐Reactive Protein‐to‐Albumin Ratio Predicts Sepsis and Prognosis in Patients with Severe Burn Injury. Mediators of Inflammation, 2021, Article ID: 6621101. [Google Scholar] [CrossRef] [PubMed]
[27] Liu, R., Xu, F., Ma, Q., Zhou, Y. and Liu, T. (2021) C‐Reactive Protein Level Predicts Cardiovascular Risk in Chinese Young Female Population. Oxidative Medicine and Cellular Longevity, 2021, Article ID: 6538079. [Google Scholar] [CrossRef] [PubMed]
[28] Yan, F., Chen, X., Quan, X., Wang, L., Wei, X. and Zhu, J. (2024) Association between the Stress Hyperglycemia Ratio and 28-Day All-Cause Mortality in Critically Ill Patients with Sepsis: A Retrospective Cohort Study and Predictive Model Establishment Based on Machine Learning. Cardiovascular Diabetology, 23, Article No. 163. [Google Scholar] [CrossRef] [PubMed]
[29] Yang, J., Zheng, Y., Li, C., Gao, J., Meng, X., Zhang, K., et al. (2022) The Impact of the Stress Hyperglycemia Ratio on Short-Term and Long-Term Poor Prognosis in Patients with Acute Coronary Syndrome: Insight from a Large Cohort Study in Asia. Diabetes Care, 45, 947-956. [Google Scholar] [CrossRef] [PubMed]
[30] Sajadieh, A., Rasmussen, V., Hein, H.O. and Hansen, J.F. (2003) Familial Predisposition to Premature Heart Attack and Reduced Heart Rate Variability. The American Journal of Cardiology, 92, 234-236. [Google Scholar] [CrossRef] [PubMed]
[31] Dekker, J.M., Crow, R.S., Folsom, A.R., Hannan, P.J., Liao, D., Swenne, C.A., et al. (2000) Low Heart Rate Variability in a 2-Minute Rhythm Strip Predicts Risk of Coronary Heart Disease and Mortality from Several Causes: The ARIC Study. Circulation, 102, 1239-1244. [Google Scholar] [CrossRef] [PubMed]
[32] Binici, Z., Mouridsen, M.R., Køber, L. and Sajadieh, A. (2011) Decreased Nighttime Heart Rate Variability Is Associated with Increased Stroke Risk. Stroke, 42, 3196-3201. [Google Scholar] [CrossRef] [PubMed]
[33] Thayer, J.F., Yamamoto, S.S. and Brosschot, J.F. (2010) The Relationship of Autonomic Imbalance, Heart Rate Variability and Cardiovascular Disease Risk Factors. International Journal of Cardiology, 141, 122-131. [Google Scholar] [CrossRef] [PubMed]
[34] Keng, H.-T., Wu, C.-C., Peng, Y.-K., et al. (2025) Derivation and Validation of Heart Rate Variability Based Machine Learning Prognostic Models for Patients with Suspected Sepsis. Biomedical Signal Processing and Control, 99, Article ID: 106854. [Google Scholar] [CrossRef
[35] Liu, H., Zhang, L., Xu, F., Li, S., Wang, Z., Han, D., et al. (2021) Establishment of a Prognostic Model for Patients with Sepsis Based on SOFA: A Retrospective Cohort Study. Journal of International Medical Research, 49, 1-15. [Google Scholar] [CrossRef] [PubMed]
[36] Guan, C., Gong, A., Zhao, Y., Yin, C., Geng, L., Liu, L., et al. (2024) Interpretable Machine Learning Model for New-Onset Atrial Fibrillation Prediction in Critically Ill Patients: A Multi-Center Study. Critical Care, 28, Article No. 349. [Google Scholar] [CrossRef] [PubMed]
[37] Fan, Z., Jiang, J., Xiao, C., Chen, Y., Xia, Q., Wang, J., et al. (2023) Construction and Validation of Prognostic Models in Critically Ill Patients with Sepsis-Associated Acute Kidney Injury: Interpretable Machine Learning Approach. Journal of Translational Medicine, 21, Article No. 406. [Google Scholar] [CrossRef] [PubMed]
[38] Preda, A., Montecucco, F., Carbone, F., Camici, G.G., Lüscher, T.F., Kraler, S., et al. (2024) SGLT2 Inhibitors: From Glucose-Lowering to Cardiovascular Benefits. Cardiovascular Research, 120, 443-460. [Google Scholar] [CrossRef] [PubMed]
[39] Chen, J., Jiang, C., Guo, M., Zeng, Y., Jiang, Z., Zhang, D., et al. (2024) Effects of SGLT2 Inhibitors on Cardiac Function and Health Status in Chronic Heart Failure: A Systematic Review and Meta-Analysis. Cardiovascular Diabetology, 23, Article No. 2. [Google Scholar] [CrossRef] [PubMed]
[40] Shashikumar, S.P., Josef, C.S., Sharma, A. and Nemati, S. (2021) DeepAISE—An Interpretable and Recurrent Neural Survival Model for Early Prediction of Sepsis. Artificial Intelligence in Medicine, 113, Article ID: 102036. [Google Scholar] [CrossRef] [PubMed]